Kereos

Company names new chief technology officer and VP, development

Published in Telemedicine Business Week, March 10th, 2004

Kereos, a company developing targeted therapeutics and molecular imaging agents for detection and treatment of cancer and cardiovascular disease, announced that it has appointed Timothy J. Pelura, PhD, to the position of chief technology officer and Dennis P. Riley, PhD, to the position of vice president of development.

"We are very pleased to have Tim and Dennis join our team. With proven track records of success, including numerous allowed INDs [investigational new drug applications] and marketing approvals between them, their expertise in both therapeutics and imaging will be invaluable to our R&D efforts," said Robert Beardsley, PhD, CEO of Kereos. "These new hires...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Telemedicine Business Week

Source: Telemedicine Business Week (2004-03-10)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry